연구물
36건 검색
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, AndrewLentzsch, SuzanneWeisel, KatjaAvet-Loiseau, HervéMark, Tomer M.신호진외 31명
- 연구출판물 · 학술지 논문Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma
Kim, Seok JinKim, KihyunKim, Byung SooLee, Hyo-JinKim, Hawk신호진외 14명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed
Kim, Hye JinYoon, Sung-SooLee, Dong SoonSohn, Sang KyunEom, Hyeon Seok정주섭외 11명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q1Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation
- 연구출판물 · 학술지 논문JCR Q4Clinical Value of Absolute Lymphocyte Counts before Bortezomib-Dexamethasone Therapy in Relapsed Multiple Myeloma Patients
- 연구출판물 · 학술지 논문JCR Q4Scopus Q4Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells
- 연구출판물 · 학술지 논문JCR Q4Scopus Q2Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
Eom, Ki-SeongKim, Seok JinLee, Je-JungSuh, CheolwonKim, Jin Seok최영진외 14명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Weisel, KatjaSpencer, AndrewLentzsch, SuzanneAvet-Loiseau, HervéMark, Tomer M.신호진외 28명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Bortezomib Inhibits Osteoclastogenesis and Porphyromonas gingivalis Lipopolysaccharide-induced Alveolar Bone Resorption
Kim, Y. -G.Kang, J. H.김형준Kim, H. J.Kim, H. -H.외 2명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
Lee, Yoo JinMoon, Joon HoSohn, Sang KyunKim, Seok JinJung, Sung-Hoon신호진외 9명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q3Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
Lee, Ho SupKim, Yang SooKim, KihyunKim, Jin SeokKim, Hyo Jung정주섭외 10명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q1Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study
최윤석심준호강가원윤상은홍준식신호진외 12명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q1Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study
정종헌김기현정성훈윤성수이재훈신호진외 8명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
Suzuki, KenshiWechalekar, Ashutosh D. D.Kim, KihyunShimazaki, ChihiroKim, Jin Seok신호진외 16명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study
- 연구출판물 · 기타JCR Q1Scopus Q1Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study
Lee, Jung YeonJung, SeungpilChoi, SueinPark, Sung-SooKim, Jin Seok신호진외 12명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)
Jung, Sung-HoonKim, DajungLee, Je-JungKim, KihyunMin, Chang-Ki신호진외 8명
- 연구출판물 · 학술지 논문JCR Q2Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety
Lee, Sung SookSuh, CheolwonKim, Bong-Seog정주섭Joo, Young-Don외 15명
- 연구출판물 · 학술지 논문Scopus Q3A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
Kim, Min KyoungKim, KihyunMin, Chang-KiKwak, Jae-YongBae, Sang-Byung신호진외 38명



로그인
홈
Researcher Page
ORCID
ISNI